Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases

Uveal melanoma is one of the most common primary intraocular malignancies that accounts for about 85% of all ocular melanomas. The pathophysiology of uveal melanoma is distinct from cutaneous melanoma and has separate tumor profiles. The management of uveal melanoma is largely dependent on the prese...

Full description

Bibliographic Details
Main Authors: Abin Sajan, Samuel Fordyce, Andrew Sideris, Connie Liou, Zeeshan Toor, John Filtes, Venkatesh Krishnasamy, Noor Ahmad, Stephen Reis, Sidney Brejt, Asad Baig, Shaheer Khan, Michael Caplan, David Sperling, Joshua Weintraub
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/13/11/1836
_version_ 1827739696113909760
author Abin Sajan
Samuel Fordyce
Andrew Sideris
Connie Liou
Zeeshan Toor
John Filtes
Venkatesh Krishnasamy
Noor Ahmad
Stephen Reis
Sidney Brejt
Asad Baig
Shaheer Khan
Michael Caplan
David Sperling
Joshua Weintraub
author_facet Abin Sajan
Samuel Fordyce
Andrew Sideris
Connie Liou
Zeeshan Toor
John Filtes
Venkatesh Krishnasamy
Noor Ahmad
Stephen Reis
Sidney Brejt
Asad Baig
Shaheer Khan
Michael Caplan
David Sperling
Joshua Weintraub
author_sort Abin Sajan
collection DOAJ
description Uveal melanoma is one of the most common primary intraocular malignancies that accounts for about 85% of all ocular melanomas. The pathophysiology of uveal melanoma is distinct from cutaneous melanoma and has separate tumor profiles. The management of uveal melanoma is largely dependent on the presence of metastases, which confers a poor prognosis with a one-year survival reaching only 15%. Although a better understanding of tumor biology has led to the development of novel pharmacologic agents, there is increasing demand for minimally invasive management of hepatic uveal melanoma metastases. Multiple studies have already summarized the systemic therapeutic options available for metastatic uveal melanoma. This review covers the current research for the most prevalent locoregional treatment options for metastatic uveal melanoma including percutaneous hepatic perfusion, immunoembolization, chemoembolization, thermal ablation, and radioembolization.
first_indexed 2024-03-11T03:09:50Z
format Article
id doaj.art-b6b121b5196f428697af934f9757a4e6
institution Directory Open Access Journal
issn 2075-4418
language English
last_indexed 2024-03-11T03:09:50Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj.art-b6b121b5196f428697af934f9757a4e62023-11-18T07:41:47ZengMDPI AGDiagnostics2075-44182023-05-011311183610.3390/diagnostics13111836Minimally Invasive Treatment Options for Hepatic Uveal Melanoma MetastasesAbin Sajan0Samuel Fordyce1Andrew Sideris2Connie Liou3Zeeshan Toor4John Filtes5Venkatesh Krishnasamy6Noor Ahmad7Stephen Reis8Sidney Brejt9Asad Baig10Shaheer Khan11Michael Caplan12David Sperling13Joshua Weintraub14Department of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Medicine, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USADepartment of Medicine, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USADepartment of Radiology, Columbia University Medical Center, 622 West 168th Street, New York, NY 10032, USAUveal melanoma is one of the most common primary intraocular malignancies that accounts for about 85% of all ocular melanomas. The pathophysiology of uveal melanoma is distinct from cutaneous melanoma and has separate tumor profiles. The management of uveal melanoma is largely dependent on the presence of metastases, which confers a poor prognosis with a one-year survival reaching only 15%. Although a better understanding of tumor biology has led to the development of novel pharmacologic agents, there is increasing demand for minimally invasive management of hepatic uveal melanoma metastases. Multiple studies have already summarized the systemic therapeutic options available for metastatic uveal melanoma. This review covers the current research for the most prevalent locoregional treatment options for metastatic uveal melanoma including percutaneous hepatic perfusion, immunoembolization, chemoembolization, thermal ablation, and radioembolization.https://www.mdpi.com/2075-4418/13/11/1836uveal melanomaliver metastasesinterventional radiologylocoregional therapy
spellingShingle Abin Sajan
Samuel Fordyce
Andrew Sideris
Connie Liou
Zeeshan Toor
John Filtes
Venkatesh Krishnasamy
Noor Ahmad
Stephen Reis
Sidney Brejt
Asad Baig
Shaheer Khan
Michael Caplan
David Sperling
Joshua Weintraub
Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
Diagnostics
uveal melanoma
liver metastases
interventional radiology
locoregional therapy
title Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
title_full Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
title_fullStr Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
title_full_unstemmed Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
title_short Minimally Invasive Treatment Options for Hepatic Uveal Melanoma Metastases
title_sort minimally invasive treatment options for hepatic uveal melanoma metastases
topic uveal melanoma
liver metastases
interventional radiology
locoregional therapy
url https://www.mdpi.com/2075-4418/13/11/1836
work_keys_str_mv AT abinsajan minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT samuelfordyce minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT andrewsideris minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT connieliou minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT zeeshantoor minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT johnfiltes minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT venkateshkrishnasamy minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT noorahmad minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT stephenreis minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT sidneybrejt minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT asadbaig minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT shaheerkhan minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT michaelcaplan minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT davidsperling minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases
AT joshuaweintraub minimallyinvasivetreatmentoptionsforhepaticuvealmelanomametastases